122 related articles for article (PubMed ID: 11444825)
1. Downregulation of p21/WAF1 expression by thymidylate synthase.
Kastanos EK; Zajac-Kaye M; Dennis PA; Allegra CJ
Biochem Biophys Res Commun; 2001 Jul; 285(2):195-200. PubMed ID: 11444825
[TBL] [Abstract][Full Text] [Related]
2. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
[TBL] [Abstract][Full Text] [Related]
4. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype.
Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW
Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789
[TBL] [Abstract][Full Text] [Related]
5. Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells.
Mohiuddin M; Chendil D; Dey S; Alcock RA; Regine W; Mohiuddin M; Ahmed MM
Anticancer Res; 2002; 22(2A):825-30. PubMed ID: 12014658
[TBL] [Abstract][Full Text] [Related]
6. The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1.
Liang SX; Richardson DR
Carcinogenesis; 2003 Oct; 24(10):1601-14. PubMed ID: 12869419
[TBL] [Abstract][Full Text] [Related]
7. In vitro transcriptional activation of p21 promoter by p53.
Kim TK
Biochem Biophys Res Commun; 1997 May; 234(2):300-2. PubMed ID: 9177263
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
[TBL] [Abstract][Full Text] [Related]
10. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
11. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.
Pocard M; Chevillard S; Villaudy J; Poupon MF; Dutrillaux B; Remvikos Y
Oncogene; 1996 Feb; 12(4):875-82. PubMed ID: 8632910
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
Kim CH; Moon SK
Arch Biochem Biophys; 2005 Mar; 435(2):264-72. PubMed ID: 15708369
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation of p53 by Pitx1.
Liu DX; Lobie PE
Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
[TBL] [Abstract][Full Text] [Related]
14. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest.
Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM
Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912
[TBL] [Abstract][Full Text] [Related]
15. Retrovirally mediated wild-type p53 restores S-phase modulation without inducing WAF1 mRNA in breast carcinoma cells containing mutant p53.
Runnebaum IB; Wang S; Kreienberg R
J Cell Biochem; 1995 Dec; 59(4):537-44. PubMed ID: 8749722
[TBL] [Abstract][Full Text] [Related]
16. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways.
Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS
Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845
[TBL] [Abstract][Full Text] [Related]
17. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
Le NT; Richardson DR
Carcinogenesis; 2003 Jun; 24(6):1045-58. PubMed ID: 12807743
[TBL] [Abstract][Full Text] [Related]
18. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
19. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
Zeng PY; Berger SL
Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of MyoD-mediated expression of p21 in tumor cell lines.
Otten AD; Firpo EJ; Gerber AN; Brody LL; Roberts JM; Tapscott SJ
Cell Growth Differ; 1997 Nov; 8(11):1151-60. PubMed ID: 9372238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
